cheasleylab · 12 papers with claims · 12 for outreach · 0 old · 0 reviews
Abstract 245: Preclinical development of HDM2020, a novel ADC targeting FGFR2b, in gastric cancer (GC) and squamous non-
New therapeutic target molecules for gastric and gastroesophageal junction cancer.
Abstract 4769: Characterization of novel humanized FGFR2b antibody-based ADCs site-specifically conjugated with topoisom
Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344.
SCR-A002, a novel FGFR2b-targeting antibody-drug-conjugate for solid tumors.
Abstract 3778: Preclinical evaluation of BG-C137, a potential first-in-class FGFR2b-targeting ADC, for the treatment of
Preclinical Efficacy of the Auristatin-Based Antibody-Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Sol
Abstract 2964: SCR-A002, a novel FGFR2b-targeting ADC for solid tumors
Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer
Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targetin
sbkim3@amc.seoul.kr
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1